Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1027 of 1,261

  1. US 7569214

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics AL, Corporation · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  2. US 7569340

    Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof

    Northwestern University · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  3. US 7569542

    Anti-microbial targeting chimeric pharmaceutical

    The Regents of the University of California · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  4. US 7569673

    Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  5. US 7569729

    Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  6. US 7569697

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  7. US 7569683

    UspA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  8. US 7569696

    Process for producing crystal

    Takeda Pharmaceutical Company Limited · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  9. US 7569604

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  10. CA 2712282

    COMPOSITION PHARMACEUTIQUE DE DULOXETINE A LIBERATION RETARDEE

    ALPHAPHARM PTY LTD [AU] · Granted Jul 30, 2009 · Expires Jul 25, 2029

    granted

  11. US 7566732

    Rhodanine compositions for use as antiviral agents

    Rigel Pharmaceuticals, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  12. US 7566718

    Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  13. US 7566552

    Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors

    CropDesign N.V. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  14. US 7566447

    Biocides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  15. US 7566451

    Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  16. US 7566462

    Stable tablet formulation

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  17. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  18. US 7566785

    Amidine substituted aryl aniline compounds

    Theravance, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  19. US 7566540

    Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

    The United States of America as represented by the Secretary of the Army · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  20. US 7566465

    Artemisinins in the clinical and veterinary management of kinetoplastid infections

    The United States of America as represented by the Secretary of the Army · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  21. US 7566714

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  22. EP 2079730

    MGLUR5-MODULATOREN

    ASTRAZENECA AB [SE] · Granted Jul 22, 2009 · Expires Jul 17, 2029

    granted

  23. EP 2079529

    ANTIMIKROBIELLE ZUSAMMENSETZUNG MIT EINEM GEHALT AN BISPYRIDINIUMALKAN (OCTENIDIN-DIHYDROCHLORID)

    AIR LIQUIDE SANTE INT [FR] · Granted Jul 22, 2009 · Expires Jul 17, 2029

    granted

  24. US 7563795

    Phenyl-piperazine derivatives as modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.